The Relation Between Serum Alpha Defensin-1 Levels with Clinical Course and Prognosis in Crimean-Congo Hemorrhagic Fever

Meral BAYAR; Emine PARLAK; Esra LALOĞLU; Mehmet PARLAK; Sinan YILMAZ

doi:https://doi.org/10.18678/dtfd.1064493

Article Details

The Relation Between Serum Alpha Defensin-1 Levels with Clinical Course and Prognosis in Crimean-Congo Hemorrhagic Fever

Authors:

Meral BAYAR | Emine PARLAK | Esra LALOĞLU | Mehmet PARLAK | Sinan YILMAZ

Publisher:

Duzce University

Main Topics:

Diseases

Journal:

Duzce Medical Journal 2022 Vol.24 Issue 1, pp.85-89

Document Type:

Article

Publication Date:

4/2022

Document Language:

English

Document ID (Org No.):

2000943828

Frequency:

Tri-annual

eISSN:

1307-671X

DOI:

https://doi.org/10.18678/dtfd.1064493

Keywords:

Abstract:

 

Aim: Crimean-Congo Hemorrhagic Fever (CCHF) is a viral zoonotic infection characterized by fever and bleeding. Alpha-defensin-1 (AD-1) is an antimicrobial peptide. The aim of this study was to investigate the relationship between the clinical course and prognosis of CCHF and AD-1 serum levels, and also to examine the role of AD-1 in the pathogenesis of the disease.
Material and Methods: Fifty patients diagnosed with CCHF and hospitalized at the Atatürk University Faculty of Medicine Department of Infectious Diseases and Clinical Microbiology, and 38 healthy control were included in this study. Serum AD-1 levels were measured using ELISA methods and compared between the groups.
Results: Serum AD-1 levels in the patients were significantly higher than those in the control group (p=0.017). Of the patients, 18 (36%) were classified as severe clinical course, 16 (32%) as moderate clinical course, and 16 (32%) as mild clinical course. There was no statistically significant difference among the three groups in terms of serum AD-1 levels (p=0.729). Median serum AD-1 levels were 171.0 (range, 126.8-221.2) ng/ml in the fatal cases, and 118.7 (range, 91.9-183.3) ng/ml in the surviving patients, and the difference between these two groups was statistically significant (p=0.014).
Conclusion: As a result, the increased serum AD-1 levels in CCHF patients, remained higher in severe course patients and in the fatal cases. On the basis of these results, AD-1 appears to indicate the clinical course and provide useful information about mortality. More extensive research should be performed to make generalizations on this subject.

 

Amaç: Kırım-Kongo Kanamalı Ateşi (KKKA), ateş ve kanama ile seyreden zoonotik viral bir enfeksiyondur. Alfa defensin-1 (AD-1) antimikrobiyal bir proteindir. Bu çalışmanın amacı AD-1 düzeyleri ile KKKA’da klinik seyir ve prognoz arasındaki ilişkiyi araştırmak, aynı zamanda AD-1’in hastalığın patogenezindeki rolünü de incelemektir.
Gereç ve Yöntemler: Bu çalışmaya KKKA tanısı almış olan ve Atatürk Üniversitesi Tıp Fakültesi Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Bölümünde yatarak takip edilen 50 hasta ve 38 sağlıklı kontrol dahil edildi. Serum AD-1 düzeyleri ELISA yöntemi ile ölçüldü ve gruplar arasında karşılaştırıldı.
Bulgular: Hastalardaki serum AD-1 düzeyleri kontrol grubundan anlamlı şekilde daha yüksekti (p=0,017). Hastaların 18 (%36)’i ağır klinik seyir, 16 (%32)’sı orta düzeyde klinik seyir ve 16 (%32)’sı hafif klinik seyir olarak sınıflandırıldı. Serum AD-1 düzeyleri açısından bu üç grup arasında istatistiksel olarak anlamlı bir farklılık yoktu (p=0,729). Ortanca serum AD-1 seviyeleri, ölümcül vakalarda 171,0 (aralık, 126,8-221,2) ng/ml ve hayatta kalan hastalarda 118,7 (aralık, 91,9-183,3) ng/ml idi ve bu iki grup arasındaki bu farklılık istatistiksel olarak anlamlı idi (p=0,014).
Sonuç: Sonuç olarak, KKKA hastalarında artan serum AD-1 düzeyleri ağır seyirli hastalarda ve ölümcül vakalarda daha da yüksek seyretmektedir. Bu sonuçlara dayalı olarak, AD-1'in klinik seyri gösterdiği ve mortalite hakkında faydalı bilgiler sağladığı görülmektedir. Bu konuda genellemeler yapabilmek için daha geniş çaplı araştırmalar yapılmalıdır.

Article Details

The Relation Between Serum Alpha Defensin-1 Levels with Clinical Course and Prognosis in Crimean-Congo Hemorrhagic Fever

Authors:

Meral BAYAR | Emine PARLAK | Esra LALOĞLU | Mehmet PARLAK | Sinan YILMAZ

Publisher:

Duzce University

Main Topics:

Diseases

Journal:

Duzce Medical Journal 2022 Vol.24 Issue 1, pp.85-89

Document Type:

Article

Publication Date:

4/2022

Document Language:

English

Document ID (Org No.):

2000943828

Frequency:

Tri-annual

eISSN:

1307-671X

DOI:

https://doi.org/10.18678/dtfd.1064493

alfa defensin-1

Antimikrobiyal peptidler

Kırım-Kongo Kanamalı Ateşi

Issues

Article Details

The Relation Between Serum Alpha Defensin-1 Levels with Clinical Course and Prognosis in Crimean-Congo Hemorrhagic Fever

Authors: Meral BAYAR | Emine PARLAK | Esra LALOĞLU | Mehmet PARLAK | Sinan YILMAZ

Publisher: Duzce University

Main Topics: Diseases

Journal: Duzce Medical Journal 2022 Vol.24 Issue 1, pp.85-89

Document Type: Article

Publication Date: 4/2022

Document Language: English

Document ID (Org No.): 2000943828

Frequency: Tri-annual

eISSN: 1307-671X

DOI: https://doi.org/10.18678/dtfd.1064493

alfa defensin-1

Antimikrobiyal peptidler

Kırım-Kongo Kanamalı Ateşi

Issues

Authors:

Meral BAYAR | Emine PARLAK | Esra LALOĞLU | Mehmet PARLAK | Sinan YILMAZ

Publisher:

Duzce University

Main Topics:

Diseases

Journal:

Duzce Medical Journal 2022 Vol.24 Issue 1, pp.85-89

Document Type:

Article

Publication Date:

4/2022

Document Language:

English

Document ID (Org No.):

2000943828

Frequency:

Tri-annual

eISSN:

1307-671X

DOI:

https://doi.org/10.18678/dtfd.1064493